首页>
外国专利>
METHOD FOR PREDICTING THE DELAY IN FORMATION OF PLACENTA AND DEVELOPMENT OF EMBRYO WITH EXACERBATION OF CYTOMEGALOVIRUS INFECTION, SUPPRESSING ACTIVITY OF THE VASCULAR ENDOTHELIAL FACTOR AND EMBRYO DEVELOPMENT
METHOD FOR PREDICTING THE DELAY IN FORMATION OF PLACENTA AND DEVELOPMENT OF EMBRYO WITH EXACERBATION OF CYTOMEGALOVIRUS INFECTION, SUPPRESSING ACTIVITY OF THE VASCULAR ENDOTHELIAL FACTOR AND EMBRYO DEVELOPMENT
展开▼
机译:预测胎盘早剥和胚发育的方法,并伴有巨细胞病毒感染的加剧,抑制血管内皮因子的活性和胚的发育
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine.SUBSTANCE: invention relates to medicine and can be used as a method for predicting the delay in the formation of the placenta and the development of the embryo in the exacerbation of cytomegalovirus infection, suppressing the activity of the vascular endothelial factor, and developing the embryo. Essence of the method: the IgG antibody titer is determined for CMV at the 7-9 week of gestation and the vascular endothelial factor VEGF-1 is determined in the chorion homogenate. In 7-9 week gestation of IgG antibody titer to CMV 1:1600, the content of vascular endothelial factor VEGF-1 decreased to 14.40±1.2 ng/ml in the chorion homogenate, which creates a threat of formation of the placenta and development of the embryo.EFFECT: invention provides an increase in the accuracy of predicting the delay in the formation of the placenta and the development of the embryo in the exacerbation of cytomegalovirus infection at the 7-9 week gestation.1 cl, 2 ex
展开▼
机译:技术领域本发明涉及医学,并且可以用作预测在巨细胞病毒感染的恶化中胎盘形成的延迟和胚胎发育,抑制血管内皮因子活性的方法,以及发育胚胎。方法的本质:在妊娠7-9周时测定CMV的IgG抗体滴度,在绒毛膜匀浆中测定血管内皮因子VEGF-1。妊娠7-9周针对CMV 1:1600的IgG抗体滴度中,绒毛膜匀浆中血管内皮因子VEGF-1的含量降至14.40±1.2 ng / ml,这对胎盘的形成和卵泡的形成具有威胁效果:本发明提高了预测在妊娠7-9周时巨细胞病毒感染加剧中胎盘形成和胚胎发育延迟的准确性。1cl,2 ex
展开▼